Fourth Dimension Wealth’s AbbVie ABBV Stock Holding History

Fourth Dimension Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$308K	Sell	1,418 -6	-0.4%	-$1.33K	0.12%	111
2025 Q4	$325K	Sell	1,424 -6	-0.4%	-$1.37K	0.12%	97
2025 Q3	$331K	Hold	1,430	–	–	0.13%	92
2025 Q2	$265K	Hold	1,430	–	–	0.11%	106
2025 Q1	$300K	Hold	1,430	–	–	0.14%	91
2024 Q4	$254K	Buy	+1,430	New	+$263K	0.13%	92

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fourth Dimension Wealth's ABBV Position: Q1 2026 in Review

Fourth Dimension Wealth reduced its AbbVie (ABBV) stake by 0.42% in Q1 2026, selling an estimated $1.33K and leaving 1,418 shares worth $308K. The position accounts for 0.12% of the portfolio, ranked #111.

Fourth Dimension Wealth first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $331K in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Fourth Dimension Wealth held 1,418 shares of AbbVie worth $308K as of Q1 2026.
Fourth Dimension Wealth sold 6 AbbVie shares in Q1 2026, an estimated $1.33K.
AbbVie made up 0.12% of Fourth Dimension Wealth's portfolio in Q1 2026, its #111 holding.
Fourth Dimension Wealth first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Fourth Dimension Wealth's AbbVie position peaked at $331K in Q3 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Fourth Dimension Wealth's 13F filing for Q1 2026, filed 11 May 2026.